Verona Pharma Share Discussion Threads

[timbo003] 10/8/2022 11:33

HTG

Old ordinary converted to new ordinaries through a 1 for 50 in 2017

1 ADR = 8 new ordinary shares

So 1 ADR = 400 old ordinary shares

[tradertrev] 10/8/2022 08:38

They are out with a 10m ADS issue which will be (maybe already has been?) underwritten. Almost certainly what caused the turn round in the price yesterday.
This should extend the cash runway well into and possibly beyond 2024 when Ensifentrine could be on the market.
There also cash milestones to come from China at some stage.

[haroldthegreat] 09/8/2022 20:53

Thank you Tim for removing the UK charts so fast ! Within the hour ! Now lets see how fast you can come up with the calculation !
Perhaps at 20:00 someone gave a small dose of Cialis I have noted the price has very slightly risen !

[haroldthegreat] 09/8/2022 20:46

How about the value in UK in £ ( or pennies ) on transfer plus details of the consolidation etc . Another task for you Tim I think ! We need an expert to work on this !

[boystown] 09/8/2022 20:30

I'd pretty much given up on these and have no idea how to value them. It's been so long now with so much dilution that I can't remember the potential valuation I put on them. I just remember reading a detailed post and analysis about nine years ago that seemed to make sense!

So ... can anyone who at least vaguely knows what they're on about here pin the tail on the donkey and say what these could / should be worth?

Thanks in advance.

[haroldthegreat] 09/8/2022 19:48

Tim perhaps you should remove the LSE VRP charts ? Looks like that the shares have flat lined . Today they have been given a shot of Viagra but like Viagra the effect on the share price is waning after a few hours !

[waterloo01] 09/8/2022 14:29

O/T If is the point. I suspect they will need to go the Verona route and raise Nasdaq funds to see it into trials. The cost to current holders might not be very palatable.

[timbo003] 09/8/2022 14:16

Agreed, but if Synairgen can hitch a ride on a platform study, the funding requirement might be quite a bit lower

[waterloo01] 09/8/2022 14:02

Indeed, although I suspect most of the early holders, unlike yourself, wouldn't have held through the raisings, placings, delistings etc to get somewhere near the end game. Given where SNG are, it would need a 200m raise, similar to here, and the dilution would be huge.

[timbo003] 09/8/2022 13:49

Yes, good idea Waterloo

This one has been a looong wait

[timbo003] 09/8/2022 13:47

Just need the second study (ENHANCE-1) to come in positive now and then we are off to the races

[waterloo01] 09/8/2022 13:46

Well done, I didn't follow this onto Nasdaq. Timbo003, you should post something in the Guild about this as is relevant to SNG and you would give that some perspective

[timbo003] 09/8/2022 13:42

Woosh !

Opened up at $12.2 on Nasdaq

[tradertrev] 09/8/2022 09:58

Last trade $8.62 on Nasdaq pre-market.

[digger18] 09/8/2022 07:58

Nice to you are still here Tim! It’s been a long ride but looks like we are finally getting somewhere. I must admit that I didn’t expect the results to be anything different, as they targeted the improvements which had already proven successful in previous trials. Just seems like a waste of a number of years coupled with massive dilution along the way.

[timbo003] 09/8/2022 07:36

Surely not, is somebody fiddling with the controls of the matrix?

Looking forward to hearing more about this result (for a change)

[digger18] 08/8/2022 22:54

Phase 3 results of Enhance2 being presented tomorrow! Hopefully a reward for long suffering holders.

[haff1] 14/7/2022 18:07

no......just laying low!

[tradertrev] 14/7/2022 08:50

Not dead yet!

[haff1] 10/6/2022 09:21

Ah...the latter ...... as expected ......and consistent with the normal dissappointments here...

[haff1] 07/6/2022 10:58

... a little promise of a better time? ..... or just the quick rise before yet another further fall?...